8593:TSEMitsubishi HC Capital Inc. Analysis
Data as of 2026-06-03 - not real-time
¥1,265.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Mitsubishi HC Capital is trading at ¥1,265, well below its 20‑day (¥1,350) and 50‑day (¥1,406) SMAs, indicating a bearish positioning, while the 14‑day RSI of 25.5 flags the stock as oversold and a potential short‑term bounce. Technical momentum remains weak as the MACD line sits below its signal line with a negative histogram, and the price hovers just above the nearest support at ¥1,239.5, leaving limited downside but a sizable upside target of roughly 15% toward the ¥1,446.5 resistance zone. The stock exhibits low market sensitivity (beta ≈ 0.20) and a 30‑day volatility of about 24%, suggesting modest price swings once the trend stabilizes.
On the valuation side, the PE of 11.2 is well under the industry average of 16.4 and the PB of 0.91 is below parity, while the dividend yield stands out at 4.11% with a comfortable payout ratio of 40%. However, the balance sheet is heavily leveraged (debt‑to‑equity ≈ 494) and operating cash flow is negative, raising concerns about cash‑flow sustainability despite a modest positive free cash flow. Overall, the stock appears fairly priced with attractive income, but the high leverage and weak cash generation temper enthusiasm, positioning it as a cautious buy for income‑focused investors.
On the valuation side, the PE of 11.2 is well under the industry average of 16.4 and the PB of 0.91 is below parity, while the dividend yield stands out at 4.11% with a comfortable payout ratio of 40%. However, the balance sheet is heavily leveraged (debt‑to‑equity ≈ 494) and operating cash flow is negative, raising concerns about cash‑flow sustainability despite a modest positive free cash flow. Overall, the stock appears fairly priced with attractive income, but the high leverage and weak cash generation temper enthusiasm, positioning it as a cautious buy for income‑focused investors.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Oversold RSI suggesting a near‑term rebound
- Price above key support level at ¥1,239.5
- Attractive dividend yield of 4.1%
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Valuation appears fair relative to peers
- High leverage and negative operating cash flow
- Stable but modest revenue growth of 3.1%
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Low beta indicating defensive characteristics
- PB below 1 and PE well under industry average
- Sustainable dividend with a payout ratio under 50%
Key Metrics & Analysis
Financial Health
Revenue Growth3.10%
Profit Margin7.32%
P/E Ratio11.2
ROE8.54%
ROA1.31%
Debt/Equity493.99
P/B Ratio0.9
Op. Cash Flow¥-367536996352
Free Cash Flow¥14.9B
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI25.5
Support¥1,239.50
Resistance¥1,446.50
MA 20¥1,350.25
MA 50¥1,406.20
MA 200¥1,319.33
MACDBearish
VolumeIncreasing
Fear & Greed Index91.96
Valuation
Target Price¥1,463.33
Upside/Downside15.68%
GradeFair
TypeBlend
Dividend Yield4.11%
Risk Assessment
Beta0.20
Volatility23.98%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.